SVRA today
$4.99+$0.07 (+1.42%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourSymmetric Triangle
1 hourBearish
15 minLeaning Bearish
5 minStrong Bearish
Daily trend turns up above $5.05
Key levels
Resistance$5.53
Resistance$5.13
Support$4.73
Support$4.33
Latest news & SEC filings
AnalystHC Wainwright starts Savara coverage with Buy rating and $10 price target
ProductSavara Shares Fresh Trial Findings on Molgramostim for aPAP
All SVRA news →About Savara
Savara is a clinical-stage pharmaceutical company developing therapies for rare respiratory diseases. Its lead product candidate is intended to treat autoimmune pulmonary alveolar proteinosis, a chronic lung condition. The company operates in the United States and is listed on the Nasdaq Global Select Market.
Based on the company's 10-K filed Mar 13, 2026.
Nasdaq · Healthcare
Savara Inc (SVRA)
What Is the Price Target for SVRA?
SEPT Low Target
$12.00
SEPT Mid Target
$12.00
SEPT High Target
$12.00
Analyst Consensus
$12.00
Is SVRA a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SVRA.
Start Free Trial →Is SVRA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$9.36
12
Moat Score
NONE
1/9
Piotroski Score
9.5
Altman Z-Score
What Is Smart Money Doing with SVRA?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Parker Braden C. | officer | Sale | 29,323 | $149K | Sep 24, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →SVRA Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-10.42%
FCF Growth YoY
-13.4%
Revenue Trend
UNKNOWN
Dark Pool Trades for SVRA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for SVRA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 12:15:33 | $5.09 | 5,000 | $$25K | BUY |
| 09:00:06 | $4.88 | 1,615 | $$8K | SELL |
| 21:00:07 | $4.99 | 2,452 | $$12K | SELL |
| 21:00:07 | $4.99 | 6,051 | $$30K | SELL |
| 21:00:00 | $4.99 | 1,065 | $$5K | BUY |
5 dark pool trades shown · $$81K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for SVRA
PREVIEWSEPT Investing provides real-time options flow tracking for SVRA, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $5 | Dec 18 | 37 | $$732 | 6 | SWEEP |
| CALL | $5 | Dec 18 | 37 | $$732 | 6 | SWEEP |
| CALL | $5 | Dec 18 | 37 | $$120 | 1 | SWEEP |
| CALL | $5 | Dec 18 | 37 | $$3000 | 25 | SWEEP |
| CALL | $5 | Nov 20 | 9 | $$10.4K | 110 | BLOCK |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Savara Inc (SVRA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →SVRA — frequently asked questions
What is SVRA stock price today?
Savara Inc (SVRA) is at $4.99, up 1.42% (+$0.07) at the Nov 11, 2026 close.
Why is SVRA stock moving today?
Latest SVRA news — Nov 12, 2026: HC Wainwright starts Savara coverage with Buy rating and $10 price target · Oct 21, 2026: Savara Shares Fresh Trial Findings on Molgramostim for aPAP
What is the SVRA price target?
The average analyst price target for SVRA is $12.00, ranging from $12 to $12, based on 1 analysts. Latest: JP Morgan initiates on Oct 7, 2026.
What do analysts rate SVRA?
Analyst ratings for SVRA: 1 Buy, 0 Hold, 0 Sell — consensus Buy.
Did SVRA beat earnings?
SVRA last reported on Aug 11, 2026: EPS -$0.16 vs -$0.14 expected — a miss of 13.2%.
Does SVRA pay a dividend?
SVRA does not currently pay a dividend.
How much debt does SVRA have?
Savara Inc reported $30M of debt and $42M of cash (Jun 30, 2026).
What are SVRA support and resistance levels?
Support: $4.73, $4.33. Resistance: $5.13, $5.53, $5.99.
What are insiders doing with SVRA?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on SVRA?
Nov 12, 2026: HC Wainwright starts Savara coverage with Buy rating and $10 price target · Oct 21, 2026: Savara Shares Fresh Trial Findings on Molgramostim for aPAP